Parliamentary Search

Written question asked by Sarah Hall (Labour) on Monday, 17 November 2025, in the House of Commons. It was due for an answer on Wednesday, 19 November 2025. It was answered by Zubir Ahmed (Labour) on Tuesday, 25 November 2025 on behalf of the Department of Health and Social Care.

Hormone Replacement Therapy: Men

Question

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential benefits of allowing men who require Hormone Replacement Therapy in the form of testosterone to be added to the HRT Prescription Prepayment Certificate.

Answer

The hormone replacement therapy prescription prepayment certificate (HRT PPC) was introduced to support women in accessing hormone replacement therapy medicines on the National Health Service as part of their care during menopause. The equalities impact assessment is available at the following link:

https://www.gov.uk/government/publications/hormone-replacement-therapy-prescription-prepayment-certificate-equality-impact-assessment/introducing-the-hrt-ppc-equality-impact-assessment#:~:text=The%20policy%20intention%20is%20that,benefit%20from%20the%20HRT%20PPC%20

Testosterone products are not in scope for the HRT PPC because, even though they can be used "off-label" to treat menopause symptoms, they are not licensed for this purpose. No United Kingdom licensed testosterone products for the treatment of menopause symptoms have been launched in the UK.

Anyone can purchase the HRT PPC if they feel that it is the most appropriate product for them. The three-month or 12-month PPC, which cover all medicines prescribed on the NHS, may be more appropriate for patients who are prescribed medicines not covered by the HRT PPC.

Secondary information

Type
Written question
Reference
91440
Session
2024-26
Subjects
Fees and charges Hormone replacement therapy Men Prescriptions
Link
View this Written question on www.parliament.uk